The SAMSUNGACTIVE KoAct US CNS Therapeutics Active ETF is an actively managed ETF that seeks capital appreciation by investing in a portfolio comprised primarily of U.S. companies involved in developing and commercializing therapies for CNS, psychiatric, and neurological disorders
The SAMSUNGACTIVE KoAct US CNS Therapeutics Active ETF (KRW) is a(n) Equity Exchange Traded Funds (ETF) seeks to invest in Healthcare sector located in USA. The Samsung Asset fund’s base currency is KRW and the share class was registered 03.09.2024 with unique ISIN - KR7490330008. Main exchange is Korea Exchange and ticker symbol is 490330. The total expense ratio is 0.5%. The SAMSUNGACTIVE KoAct US CNS Therapeutics Active ETF (KRW) pays dividends 1 time(s) per year.